Dachaigh › Neurofibroma Plexiform
Sgrùdaidhean clionaigeach Neurofibroma Plexiform a’ fastadh anns na SA
Tha 8 sgrùdaidhean airson Neurofibroma Plexiform a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Washington, DC7 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Birmingham, AL4 sgrùdaidhean
- Indianapolis, IN3 sgrùdaidhean
- Cincinnati, OH3 sgrùdaidhean
- Dallas, TX3 sgrùdaidhean
- Los Angeles, CA3 sgrùdaidhean
Le stàit
- Alabama4 sgrùdaidhean
- California3 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Maryland6 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Pennsylvania4 sgrùdaidhean
- Sgìre Cholumbia4 sgrùdaidhean
- Texas3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
A’ fastadhÌre 1
Aoisean 16 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06502171Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 5 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
A’ fastadhSgrùdadh amharc
Aoisean 3 gu 120 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
A’ fastadhÌre 1
Aoisean 3 gu 35 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT02390752A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 29 Iuch 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
A’ fastadh
Aoisean 1 gu 120 · Gach gnè · Air ùrachadh 9 Ògmh 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
A’ fastadhÌre 2
Aoisean 1 gu 8 · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT06188741PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Dùbh 2025 · NCT06961565Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.